exosomes from mesenchymal stem cells
Vaccineexperimental
Clinical trial activity
62 trials · 52 clinical orgs · 0 marketing orgs
Phase 1
46
Phase 2
29
Phase 3
3
Phase 4
0
Earliest trial started Sep 30, 2015 (NCT02565264)
Timeline
Indications
Studied for
- Acute-On-Chronic Liver Failure · Phase 1/Phase 2
- Aging · Phase 1/Phase 2
- Alopecia · Phase 3
- Alzheimer Disease · Phase 1/Phase 2
- Anemia · Phase 1
- Autoimmune Diseases · Phase 1/Phase 2
- Cell- and Tissue-Based Therapy · Phase 1/Phase 2
- Cognitive Dysfunction · Phase 1/Phase 2
- Colitis, Ulcerative · Phase 1
- Coronavirus · Phase 1
- COVID-19 · Phase 2
- Crohn Disease · Phase 1/Phase 2
- Diabetes Mellitus, Type 2 · Phase 2
- Diabetic Foot · Phase 2
- Dry Eye Syndromes · Phase 1/Phase 2
- Dyspnea · Phase 1/Phase 2
- Endothelial Cells · Phase 1/Phase 2
- Exosomes · Phase 3
- Extracellular Vesicles · Phase 1
- Graft Rejection · Early Phase 1
- Healthy Volunteers · Phase 1
- Hemorrhage · Phase 1
- Infections · Phase 1/Phase 2
- Infertility, Female · Phase 1/Phase 2
- Inflammatory Bowel Diseases · Phase 1
- Irritable Bowel Syndrome · Phase 1
- Ischemic Stroke · Phase 1
- Leukemia, Myeloid, Acute · Phase 1
- Liver Cirrhosis · Phase 2
- Liver Failure · Phase 1
- Liver Failure, Acute · Phase 1/Phase 2
- Mesenchymal Stem Cells · Phase 1
- Motor Disorders · Phase 1
- Multiple Sclerosis · Early Phase 1
- Myasthenic Syndromes, Congenital · Phase 1
- Myocardial Infarction · Phase 1/Phase 2
- Myocardial Ischemia · Phase 1/Phase 2
- Myocardial Stunning · Phase 1/Phase 2
- Neutropenia · Phase 1
- Osteoarthritis, Knee · Phase 1
- Periodontitis · Early Phase 1
- Pharmacology · Phase 1/Phase 2
- Pneumonia · Phase 1/Phase 2
- Postpartum Period · Phase 1/Phase 2
- Pre-Eclampsia · Phase 1/Phase 2
- Prospective Studies · Phase 1/Phase 2
- Rectal Fistula · Phase 1/Phase 2
- Rectal Neoplasms · Phase 1
- Respiratory Distress Syndrome · Phase 3
- Retinal Perforations · Early Phase 1
- Retinitis Pigmentosa · Phase 1/Phase 2
- Safety · Phase 1
- Severe Acute Respiratory Syndrome · Phase 3
- Tennis Elbow · Phase 1/Phase 2
- Thrombocytopenia · Phase 1
- Tissue Adhesions · Phase 1/Phase 2
- Ulcer · Early Phase 1
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigen
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- exosomes from mesenchymal stem cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07312656 | Phase 2 | Jan 31, 2026 | First People's Hospital of Yulin, Hacettepe University |
| NCT07295067 | Phase 1 | Dec 15, 2025 | Capital Medical University |
| NCT07243561 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2025 | Dongfang People's Hospital |
| NCT07131683 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2025 | Capital Medical University |
| NCT07203599 | Phase 1/Phase 2 (Phase 2) | Sep 20, 2025 | Shenzhen University |
| NCT07144241 | Phase 2 | Sep 1, 2025 | University of Indonesia |
| NCT07112586 | Phase 1/Phase 2 (Phase 2) | Aug 30, 2025 | Ain Shams University |
| NCT06853522 | Early Phase 1 (Phase 1) | May 30, 2025 | Huazhong University of Science and Technology |
| NCT06932393 | Early Phase 1 (Phase 1) | Apr 30, 2025 | Guangzhou Bio-gene Technology Co., Ltd. |
| NCT06919380 | Phase 1 | Apr 15, 2025 | Guangzhou Medical University |
| NCT06825572 | Phase 1 | Apr 1, 2025 | Sun Yat-Sen University |
| NCT07145294 | Phase 1/Phase 2 (Phase 2) | Mar 7, 2025 | Jiao Tong University |
| NCT07281690 | Phase 3 | Mar 1, 2025 | Laser Beamer Skincare |
| NCT06896747 | Phase 1/Phase 2 (Phase 2) | Feb 21, 2025 | Air Force Military Medical University, China, Jiao Tong University, People's Liberation Army of China |
| NCT06429033 | Phase 1 | Jan 1, 2025 | The Clinical Testing Center of Beverly Hills |
| NCT07226726 | Phase 1 | Jan 1, 2025 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT06536712 | Phase 1 | Aug 31, 2024 | University of Tehran |
| NCT06543667 | Phase 1 | Aug 1, 2024 | Iran University of Medical Sciences |
| NCT06482541 | Phase 1 | Jul 31, 2024 | Levit Dermatology |
| NCT07105371 | Phase 1 | Jul 14, 2024 | The Foundation for Orthopaedics and Regenerative Medicine |
Showing 20 of 62 trials
Page 1 / 4
Organizations
Research & Development (52)
52 organizations
Page 1 / 3